GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pulike Biological Engineering Inc (SHSE:603566) » Definitions » 3-Year EBITDA Growth Rate

Pulike Biological Engineering (SHSE:603566) 3-Year EBITDA Growth Rate : -5.60% (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Pulike Biological Engineering 3-Year EBITDA Growth Rate?

Pulike Biological Engineering's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.09.

During the past 12 months, Pulike Biological Engineering's average EBITDA Per Share Growth Rate was -32.80% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -5.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 8.50% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 2.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Pulike Biological Engineering was 34.90% per year. The lowest was -20.40% per year. And the median was -3.25% per year.


Competitive Comparison of Pulike Biological Engineering's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Pulike Biological Engineering's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pulike Biological Engineering's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pulike Biological Engineering's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Pulike Biological Engineering's 3-Year EBITDA Growth Rate falls into.



Pulike Biological Engineering 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Pulike Biological Engineering  (SHSE:603566) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Pulike Biological Engineering 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Pulike Biological Engineering's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Pulike Biological Engineering (SHSE:603566) Business Description

Traded in Other Exchanges
N/A
Address
15th New governance, Henan Province, Luoyang, CHN, 471000
Pulike Biological Engineering Inc is engaged in the research and development and production and operation of veterinary drugs.
Executives
Sun Jin Zhong Director
Zhang Zhen Supervisors
Wang Zhu Yi Supervisors
Ma Sui Ying Director
Song Yong Jun Director
Hu Wei Director
Qiao Rong Cen senior management
Zhou Li Peng senior management
Tian Ke Gong senior management
Kang Du Li senior management
Zhao Rui senior management
Qin De Chao Director
Pei Lian Feng senior management
Zhang Li Chang Director
Zhang Xu Ke Director

Pulike Biological Engineering (SHSE:603566) Headlines

No Headlines